SAMIT MEHTA COO
Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across ...
NTAGI could decide on mRNA vaccine's inclusion in national drive next weekIndia's drug regulator approved Gennova's mRNA vaccine for restricted use in emergency situations in adults early this week.
- Load More